United Therapeutics Stock Forecast - Simple Exponential Smoothing
| UTHR Stock | USD 468.94 3.12 0.66% |
The Simple Exponential Smoothing forecasted value of United Therapeutics on the next trading day is expected to be 468.94 with a mean absolute deviation of 5.54 and the sum of the absolute errors of 332.44. United Stock Forecast is based on your current time horizon. Although United Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of United Therapeutics' systematic risk associated with finding meaningful patterns of United Therapeutics fundamentals over time.
As of today the rsi of United Therapeutics' share price is below 20 . This usually implies that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Quarterly Earnings Growth 0.121 | EPS Estimate Next Quarter 6.5091 | EPS Estimate Current Year 27.0015 | EPS Estimate Next Year 28.5888 | Wall Street Target Price 530.835 |
Using United Therapeutics hype-based prediction, you can estimate the value of United Therapeutics from the perspective of United Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards United Therapeutics using United Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards United using crowd psychology based on the activity and movement of United Therapeutics' stock price.
United Therapeutics Short Interest
An investor who is long United Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about United Therapeutics and may potentially protect profits, hedge United Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 377.8221 | Short Percent 0.0566 | Short Ratio 4.02 | Shares Short Prior Month 2.1 M | 50 Day MA 485.5696 |
United Therapeutics Hype to Price Pattern
Investor biases related to United Therapeutics' public news can be used to forecast risks associated with an investment in United. The trend in average sentiment can be used to explain how an investor holding United can time the market purely based on public headlines and social activities around United Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
United Therapeutics Implied Volatility | 0.44 |
United Therapeutics' implied volatility exposes the market's sentiment of United Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if United Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that United Therapeutics stock will not fluctuate a lot when United Therapeutics' options are near their expiration.
The Simple Exponential Smoothing forecasted value of United Therapeutics on the next trading day is expected to be 468.94 with a mean absolute deviation of 5.54 and the sum of the absolute errors of 332.44. United Therapeutics after-hype prediction price | USD 468.82 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of United Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current United contract
Based on the Rule 16, the options market is currently suggesting that United Therapeutics will have an average daily up or down price movement of about 0.0275% per day over the life of the 2026-04-17 option contract. With United Therapeutics trading at USD 468.94, that is roughly USD 0.13 . If you think that the market is fully incorporating United Therapeutics' daily price movement you should consider acquiring United Therapeutics options at the current volatility level of 0.44%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 United Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast United Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in United Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for United Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current United Therapeutics' open interest, investors have to compare it to United Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of United Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in United. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
United Therapeutics Additional Predictive Modules
Most predictive techniques to examine United price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for United using various technical indicators. When you analyze United charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
United Therapeutics Simple Exponential Smoothing Price Forecast For the 26th of January
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of United Therapeutics on the next trading day is expected to be 468.94 with a mean absolute deviation of 5.54, mean absolute percentage error of 60.98, and the sum of the absolute errors of 332.44.Please note that although there have been many attempts to predict United Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that United Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
United Therapeutics Stock Forecast Pattern
| Backtest United Therapeutics | United Therapeutics Price Prediction | Buy or Sell Advice |
United Therapeutics Forecasted Value
In the context of forecasting United Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. United Therapeutics' downside and upside margins for the forecasting period are 467.22 and 470.66, respectively. We have considered United Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of United Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent United Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 120.3831 |
| Bias | Arithmetic mean of the errors | -0.8933 |
| MAD | Mean absolute deviation | 5.5407 |
| MAPE | Mean absolute percentage error | 0.0116 |
| SAE | Sum of the absolute errors | 332.44 |
Predictive Modules for United Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as United Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.United Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of United Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in United Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of United Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
United Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting United Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on United Therapeutics' historical news coverage. United Therapeutics' after-hype downside and upside margins for the prediction period are 467.10 and 470.54, respectively. We have considered United Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
United Therapeutics is very steady at this time. Analysis and calculation of next after-hype price of United Therapeutics is based on 3 months time horizon.
United Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as United Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading United Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with United Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.19 | 1.72 | 0.12 | 0.06 | 31 Events / Month | 7 Events / Month | In about 31 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
468.94 | 468.82 | 0.03 |
|
United Therapeutics Hype Timeline
United Therapeutics is at this time traded for 468.94. The entity has historical hype elasticity of -0.12, and average elasticity to hype of competition of -0.06. United is forecasted to decline in value after the next headline, with the price expected to drop to 468.82. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.03%, whereas the daily expected return is at this time at 0.19%. The volatility of related hype on United Therapeutics is about 583.05%, with the expected price after the next announcement by competition of 468.88. About 98.0% of the company outstanding shares are owned by institutional investors. The book value of United Therapeutics was at this time reported as 153.61. The company has Price/Earnings To Growth (PEG) ratio of 1.43. United Therapeutics recorded earning per share (EPS) of 26.4. The entity had not issued any dividends in recent years. The firm had 2:1 split on the 23rd of September 2009. Given the investment horizon of 90 days the next forecasted press release will be in about 31 days. Check out Historical Fundamental Analysis of United Therapeutics to cross-verify your projections.United Therapeutics Related Hype Analysis
Having access to credible news sources related to United Therapeutics' direct competition is more important than ever and may enhance your ability to predict United Therapeutics' future price movements. Getting to know how United Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how United Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| INCY | Incyte | 0.83 | 10 per month | 1.72 | 0.09 | 4.10 | (2.92) | 14.33 | |
| GMAB | Genmab AS | (0.01) | 26 per month | 1.86 | 0.05 | 4.09 | (3.16) | 9.07 | |
| RPRX | Royalty Pharma Plc | 0.11 | 4 per month | 1.47 | 0.06 | 2.13 | (2.28) | 12.26 | |
| DGX | Quest Diagnostics Incorporated | (3.06) | 9 per month | 0.00 | (0.1) | 2.68 | (2.28) | 6.29 | |
| ZBH | Zimmer Biomet Holdings | (1.35) | 8 per month | 0.00 | (0.13) | 2.92 | (2.20) | 18.45 | |
| THC | Tenet Healthcare | 0.63 | 34 per month | 0.00 | (0.07) | 3.14 | (3.00) | 14.80 | |
| ILMN | Illumina | 0.69 | 10 per month | 1.37 | 0.16 | 4.19 | (2.83) | 28.04 | |
| WST | West Pharmaceutical Services | 2.06 | 8 per month | 0.00 | (0.11) | 2.56 | (3.58) | 17.94 | |
| WAT | Waters | 4.27 | 9 per month | 0.87 | 0.09 | 3.35 | (1.83) | 8.38 | |
| BIIB | Biogen Inc | (7.12) | 10 per month | 1.62 | 0.1 | 3.11 | (2.55) | 9.61 |
Other Forecasting Options for United Therapeutics
For every potential investor in United, whether a beginner or expert, United Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. United Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in United. Basic forecasting techniques help filter out the noise by identifying United Therapeutics' price trends.United Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with United Therapeutics stock to make a market-neutral strategy. Peer analysis of United Therapeutics could also be used in its relative valuation, which is a method of valuing United Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
United Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how United Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading United Therapeutics shares will generate the highest return on investment. By undertsting and applying United Therapeutics stock market strength indicators, traders can identify United Therapeutics entry and exit signals to maximize returns.
| Accumulation Distribution | 0.0228 | |||
| Daily Balance Of Power | (0.29) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 469.58 | |||
| Day Typical Price | 469.36 | |||
| Market Facilitation Index | 10.83 | |||
| Price Action Indicator | (2.20) | |||
| Period Momentum Indicator | (3.12) |
United Therapeutics Risk Indicators
The analysis of United Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in United Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting united stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.19 | |||
| Semi Deviation | 1.16 | |||
| Standard Deviation | 1.72 | |||
| Variance | 2.96 | |||
| Downside Variance | 1.57 | |||
| Semi Variance | 1.34 | |||
| Expected Short fall | (1.36) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for United Therapeutics
The number of cover stories for United Therapeutics depends on current market conditions and United Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that United Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about United Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
United Therapeutics Short Properties
United Therapeutics' future price predictability will typically decrease when United Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of United Therapeutics often depends not only on the future outlook of the potential United Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. United Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 48.5 M | |
| Cash And Short Term Investments | 3.3 B |
Additional Tools for United Stock Analysis
When running United Therapeutics' price analysis, check to measure United Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy United Therapeutics is operating at the current time. Most of United Therapeutics' value examination focuses on studying past and present price action to predict the probability of United Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move United Therapeutics' price. Additionally, you may evaluate how the addition of United Therapeutics to your portfolios can decrease your overall portfolio volatility.